INS and type 2 diabetes mellitus: Here, we show that de novo production of sphingolipids is required for normal secretion of insulin by human islet cells in vitro, since application of sphingolipid synthesis inhibitor myriocin dampened the basal levels of secreted insulin in both ND and T2D human islet cells (Fig 6A–6C).